An epidemiological study of head trauma patients receiving antithrombotic drugs
Not Applicable
- Conditions
- traumatic brain injury
- Registration Number
- JPRN-UMIN000037283
- Lead Sponsor
- The Japan Society of Neurotraumatology
- Brief Summary
[Results] In this study, 721 patients were examined. The rates of deterioration during the course were 9.8%, 15.8%, and 31.0% in groups A, B, and C, respectively, showing statistically significant differences. The favorable outcome rates were 57.1%, 52.5%, and 35.8%. The mortality rate was 14.5%, 18.0%. 24.5%. The time from injury to reversal therapy was significantly shorter in the patients without deterioration or in the favorable outcome group (405.9 vs. 880.8 minutes, 261.9 vs 543.4 minutes).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 721
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Chronic subdural hematoma (2) Patients with cardiopulmonary arrest on arrival
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A national survey regarding age/sex/injury mechanism/diagnosis/compliance with antithrombotic drugs/neutralization of these drugs/outcomes involving patients with head trauma will be conducted. Furthermore, whether the contents of treatment influence the outcome will be investigated.In registered patients with head trauma, the status/treatment during the admission period will be examined. Approximately 90 items will be observed. The outcome will be assessed on discharge and 6 months after injury. The observation period is 6 months after injury at maximum.
- Secondary Outcome Measures
Name Time Method